data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
Watch
YouTube
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
AnaptysBio
(NASDAQ:ANAB)
$24.69
1.54[6.65%]
At close: Aug 5
$24.69
After Hours: 4:01PM EDT
Day High/Low22.52 - 24.69
52 Week High/Low18.2 - 36.06
Open / Close22.78 / 24.69
Float / Outstanding19.7M / 28.2M
Vol / Avg.206.7K / 322.8K
Mkt Cap695.9M
P/E-
50d Avg. Price21.12
Div / Yield-
Payout Ratio-
EPS-1.31
Total Float19.7M

AnaptysBio (NASDAQ:ANAB), Quotes and News Summary

AnaptysBio (NASDAQ: ANAB)

Day High/Low22.52 - 24.69
52 Week High/Low18.2 - 36.06
Open / Close22.78 / 24.69
Float / Outstanding19.7M / 28.2M
Vol / Avg.206.7K / 322.8K
Mkt Cap695.9M
P/E-
50d Avg. Price21.12
Div / Yield-
Payout Ratio-
EPS-1.31
Total Float19.7M
Sector: Health Care.Industry: Biotechnology
AnaptysBio Inc is clinical-stage biotechnology company. It is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company develops product candidates to address emerging biological targets using its proprietary, antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation. Its product candidates are ANB020, ANB019, and Checkpoint receptor agonist. The entity generates revenue from the collaborative research and development arrangements.
Read More

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-03
REV
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-19
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

AnaptysBio Questions & Answers

Q
How do I buy AnaptysBio (ANAB) stock?
A

You can purchase shares of AnaptysBio (NASDAQ: ANAB) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are AnaptysBio's (ANAB) competitors?
Q
What is the target price for AnaptysBio (ANAB) stock?
A

The latest price target for AnaptysBio (NASDAQ: ANAB) was reported by Guggenheim on Tuesday, March 22, 2022. The analyst firm set a price target for 0.00 expecting ANAB to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.

Q
Current Stock Price for AnaptysBio (ANAB)?
A

The stock price for AnaptysBio (NASDAQ: ANAB) is $24.69 last updated August 5, 2022, 8:00 PM UTC.

Q
Does AnaptysBio (ANAB) pay a dividend?
A

There are no upcoming dividends for AnaptysBio.

Q
When is AnaptysBio (NASDAQ:ANAB) reporting earnings?
A

AnaptysBio’s Q3 earnings are confirmed for Thursday, November 3, 2022.

Q
Is AnaptysBio (ANAB) going to split?
A

There is no upcoming split for AnaptysBio.

Q
What sector and industry does AnaptysBio (ANAB) operate in?
A

AnaptysBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.